Podcasts about cancer screenings

Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates

Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates

Join Dr. Jill Valerius and host Lee Henrikson as they continue to discuss vaping dangers and begin a discussion on prostate cancer screening.

Program notes:0:35 Cell-free DNA screening for cancer and diagnosis delays1:35 Populations-based screening2:35 24 different companies offer liquid biopsy3:01 Can we prevent chronic back pain after acute back pain?4:01 Impact score on chronic back pain5:01 Real-world setting lacks impact6:01 Primary care role7:01 Individual should assess their own back pain7:25 Resistance training and mortality8:25 Most benefit with aerobic and resistance training9:20 GLP1 and knee arthroplasty10:20 Using a GLP1 reduced risk of knee arthroplasty11:23 Can't imagine using them solely for this purpose12:25 End

On today's episode, we sit down with Dr. James Cates talking all things men's health in honor of Men's Health Month. Starting off with his medical background and misconceptions around men's health. They also touch on the use of GLP-1 medications and changes in weight loss. As well as supplementing water and protein for proper weight loss without the medication. From GLP-!s to Cancer Screenings and everything in between, men's health is more important than ever to keep track of and discuss. Listen To The Local Matters Podcast Today! News Talk 94.1

Health care policy plays a critical role in who gets screened for cancer and who can afford it. In the miniVHAN with us is, Maddie Michael of the American Cancer Society Cancer Action Network who shares how advocacy, legislation and community voices shape access to cancer care and improve outcomes.

The American Cancer Society (ACS) recently updated its colorectal cancer screening recommendations, adding new stool-based and blood-based screening options. What's changed in the new American Cancer Society screening recommendations • New stool DNA and stool RNA screening tests • The role of blood-based cancer screening tests • Why colonoscopy remains the gold standard • Why a follow-up colonoscopy is still needed after a positive screening test • Screening recommendations for adults ages 45–75 • The rise in colorectal cancer among younger adults and what patients should know The most important takeaway? Colorectal cancer is highly preventable, and the best screening test is the one that gets completed. This episode is intended for educational purposes only and should not replace medical advice from your healthcare provider.  

Police apologise for arresting a dying teen, stabbed with a ceremonial knife, after his killer's 'wicked' racism lie. Dame Helen Mirren is verbally abused in the street by a pro-Palestinian activist and Health officials reject calls for mass screening for prostate cancer by rationing it to only "a few thousand" men.

Taylor Dayne brings her good to our 250th episode. She's a Grammy-nominated, American Music Award-winning vocal powerhouse who has conquered the Top 20 on the Billboard Top 100 chart 17 times landing 7 times in the Top 10.Taylor's unbelievable career ascent has taken her from sold-out rock concerts to starring on Broadway in Aida to the semi-finals of the Masked Singer. In 2022, an unexpected diagnosis of colon cancer did little to slow her down and made her an advocate for promoting early detection and regular cancer screenings. We talk with Taylor about what drives her, how she chooses her songs (or if they choose her), and exactly what was that whole thing with Tig Notaro even about. This is a reunion of sorts as World Gone Good host, Steve, originally met Taylor at a mutual friend's last-minute cocktail hour in Santa Barbara. Funny how things work out, ain't it? Get ready to 'Tell It To My Heart' with the amazing Taylor Dayne here with us to celebrate episode #250! __________________ June 13 and July 12 - grab your seat to SLIDESHOW: IN COLOR! now playing in London. It's the live storytelling show the Los Angeles Times declares, "Downright magical, uncomfortable and shockingly honest!" and Theatreland Adventures London cheers, "FOUR STARS - This is unlike anything I've seen before, a warm, engaging, and memorable evening!" Tickets & Info: https://www.citizenticket.com/events/etcetera-theatre/slideshow-in-color/ Pre-Order CUPID'S CURSE - the fourth book in Steve's series THE DOG WALKING DETECTIVES MYSTERIES and catch up on the rest: https://www.barnesandnoble.com/s/%22Steven+J+Silverman%22?Ntk=Publisher&Ns.

Editor's Summary by Preeti Malani, MD, MSJ, and Tracy Lieu, MD, MPH, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from May 16-22, 2026.

In this episode of the Clinical Update podcast, MIMS Learning deputy editor Rhiannon and medical editor Dawn provide a comprehensive update on prostate health. High-profile figures, such as Sir Chris Hoy, opening up about their own diagnoses have significantly increased public awareness of prostate cancer. In light of this, the editors discuss the rationale for targeted prostate cancer screening and patient counselling around prostate-specific antigen (PSA) tests. The conversation also highlights health inequalities in prostate cancer diagnosis, noting that Black men have double the risk of prostate cancer compared with other groups, and highlighting care for trans women, who may remain at risk of prostate cancer after gender-confirming surgery.Beyond malignancy, this episode covers the symptoms and management of benign prostatic hyperplasia (BPH) and chronic prostatitis in primary care.Educational objectivesAfter listening to this podcast, healthcare professionals should be better able to:Recall draft recommendations for targeted prostate cancer screening in high-risk groupsIdentify key risk factors for prostate cancer, including ethnicity and ageOutline factors that can raise or suppress PSA levelsUnderstand the diagnostic pathway and the role of digital rectal examinationRecognise symptoms and potential complications of BPH and prostatitisYou can access the website version of this podcast, along with a list of key learning points, on MIMS Learning - and make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.This episode was produced by Jude Owen.MIMS LearningRegister for a FREE accountExpert perspective: prostate cancer diagnosisGuidance update: NICE guidelines on prostate cancerLatest updates in prostate cancer for primary careBenign prostatic hyperplasia: clinical reviewProstate Cancer UK Hosted on Acast. See acast.com/privacy for more information.

Join Dr. Jill Valerius and host Lee Henrikson as they begin a three-part series discussing lung cancer screenings.

This clip comes from Dr. Raj's series with My Care Friends. Watch the video here: https://www.youtube.com/watch?v=ULrG2LLI9Ww About Dr. Raj Dr. Raj Dasgupta is an ABIM Quadruple board-certified physician specializing in internal medicine, pulmonology, critical care, and sleep medicine. He is currently the Associate Program Director of Internal Medicine Residency at Huntington Health in Pasadena, California and an Associate Professor of Clinical Medicine for the University of California, Riverside School of Medicine (UCR). He previously practiced at the University of Southern California, where he is an associate professor of clinical medicine, assistant program director of the Internal Medicine Residency Program, and the associate program director of the Sleep Medicine Fellowship. Dr. Dasgupta is an active clinical researcher and has been teaching around the world for more than 20 years. More from Dr. Raj The Dr. Raj Podcast Dr. Raj on Twitter Dr. Raj on Instagram Want more board review content? USMLE Step 1 Ad-Free Bundle Crush Step 1 Step 2 Secrets Beyond the Pearls The Dr. Raj Podcast Beyond the Pearls Premium USMLE Step 3 Review MedPrepTGo Step 1 Questions MedPrepTGo Step 2 Questions Follow MedPrepToGo https://medpreptogo.com https://www.instagram.com/medpreptogo/ https://www.linkedin.com/company/medpreptogo/ https://www.facebook.com/MedPrepToGo/ https://www.youtube.com/@MedPrepToGo Learn more about your ad choices. Visit megaphone.fm/adchoices

Grace is joined by Boston City Councilor Erin Murphy to discuss Durkan killing the firefighter cancer screening vote. Then, Grace found a new game called "Are You A Fascist?".  Visit the Howie Carr Radio Network website to access columns, podcasts, and other exclusive content.

What if the mammogram your doctor relies on is actually doing more harm than good, and a better option already exists? Dr. Cara Fuhrman, naturopathic doctor, Medical Director of Longevity RX, and daughter of nutritional science pioneer Dr. Joel Fuhrman, joins Integrative Cancer Solutions to break down the serious limitations of routine mammography, including staggering rates of overdiagnosis and overtreatment, and makes the case for QT Imaging as a radiation-free, far more accurate alternative. The conversation covers the three hormones silently fueling cancer growth, how everyday foods like white rice and animal protein accelerate tumor progression, and the anti-cancer power of cruciferous vegetables, flaxseeds, and raw garlic. If you want a more informed, proactive approach to breast cancer prevention, this episode delivers what your doctor may never tell you. Key Takeaways: 0:00 Introduction 0:32 Growing up with Dr. Joel Fuhrman and the nutritarian legacy 6:02 Layering herbs technology and nutrition to stop cancer 10:02 Mammogram overdiagnosis is harming more people than it helps 17:07 QT Imaging the radiation-free alternative to mammography 23:07 Why biopsies are overused and what to do instead 28:44 The three hormones silently fueling cancer growth 33:19 GBOMBS flaxseeds and garlic as everyday cancer medicine Resources: Dr. Cara's Instagram - https://www.instagram.com/drcarafuhrman/ Longevity RX -https://trylongevityrx.com/ Dr. Joel Fuhrman - https://www.drfuhrman.com Nordic Cochrane Centre - https://www.cochrane.org/ QT Imaging - https://www.qtimaging.com TerraSoul Superfoods - https://www.terrasoul.com Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions. ____________________________________RESOURCES FROM DR. KARLFELDT:

Cancer screenings can save lives, but the right screening plan can change as we age. In this episode of The University of Kansas Health System Open Mics, Dr. Steve Stites talks with geriatric medicine specialist Dr. Jessica Kalender-Rich and clinical oncologist Dr. Nina Mathew about cancer screenings for older adults and how seniors can make informed decisions about early detection. The conversation covers common screenings such as colonoscopy, mammograms, prostate cancer screening, lung cancer screening and skin cancer checks. The doctors also discuss why some screenings stop at a certain age, how health status and personal risk affect recommendations, and how patients can weigh the benefits and risks of routine cancer screening. They also look at newer options, including blood-based multi-cancer early detection tests, mail-in colon cancer screening, and mobile cancer screening programs designed to reach rural communities.

We bring back the biggest takeaways from the ACOG ACSM, then move fast through the newest guidance and the newest hype shaping real OBGYN care. We focus on what the evidence actually supports, where practice still lags behind, and how “labels” can quietly push patients toward harm.• conference highlights including rural OBGYN access and what gets attention on the exhibit floor • vitamin K shot refusal trends and why late bleeding still matters weeks after birth • 2026 ACOG cervical cancer screening changes with primary HPV testing preferred for ages 30 to 65 • self-collected HPV screening and the systems needed to keep follow-up safe • why annual Pap testing and cytology-only strategies increase overdiagnosis and can miss HPV risk • postmenopausal bleeding workup shifting toward ultrasound plus endometrial biopsy up front • large baby induction data and why outcomes can worsen without neonatal benefit • third-trimester ultrasound screening performance and the real-world labeling effect • early proof-of-concept therapy for preeclampsia targeting sFlt1 removal to prolong pregnancy • hysterectomy duration and route as drivers of venous thromboembolism risk • laboring down claims from retrospective reports versus randomized trial findings • debunking physiologic third stage claims and reaffirming active management to prevent hemorrhage Be sure to check out thinkingaboutobgyn.com for more information, and be sure to follow us on Instagram.0:00 ACOG Meeting Takeaways And Rural Access3:58 Vitamin K Refusal And Newborn Bleeding6:37 Cervical Screening Moves Toward HPV14:48 Postmenopausal Bleeding Now Needs Biopsy20:00 Tylenol Data And Macrosomia Induction28:34 Ultrasound Labeling Effect And Liability Fears37:29 Removing sFlt1 To Buy Time40:14 Longer Hysterectomy Surgeries Raise VTE Risk42:14 Laboring Down Claims Versus RCT Reality49:59 Counseling Fatigue Without Ignoring Risk54:21 Third Stage Myths And Hemorrhage Prevention58:42 Evidence Literacy And Closing NotesFollow us on Instagram @thinkingaboutobgyn.

Early colorectal cancer usually causes no symptoms, which means the only way to catch it at a truly curable stage—or even prevent it altogether—is through regular screening, especially colonoscopy. During a colonoscopy, doctors can not only find cancers earlier, when treatment is more effective and survival rates are much higher, but also remove precancerous polyps on the spot, stopping many cancers before they ever form. National guidelines now recommend that average‑risk adults begin colorectal cancer screening at age 45 and continue at regular intervals, using colonoscopy every 10 years or other approved tests, because this simple step has been shown to significantly lower both the incidence of colorectal cancer and deaths from the disease.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter takes a deep dive into colorectal cancer (CRC) screening, explaining why it is one of the most preventable cancers and why getting screening right can have life-saving implications. He walks through how colorectal cancer develops and why it is uniquely well-suited to early detection and prevention, with a particular emphasis on the dual role of colonoscopy as both a diagnostic and therapeutic tool. Peter also examines the concerning rise in early-onset CRC among younger adults, highlighting why awareness and timely screening matter more than ever. The episode provides a practical guide to preparing for and evaluating the quality of a colonoscopy, including how to think about appropriate screening intervals and the real risks and tradeoffs involved. Finally, Peter explores the expanding landscape of non-invasive screening options, offering clear insight into what these alternatives can and cannot do so listeners can make informed decisions about their care at any age. We discuss: CRC statistics and goals for this episode [1:00]; Colorectal cancer development: polyp progression, risk types, and the window for prevention [4:00]; Why colorectal cancer is uniquely screenable: direct visualization and the dual role of colonoscopy [6:30]; Colonoscopy effectiveness: prevention through polyp removal and interpreting the NordICC trial data [8:15]; Rising colorectal cancer in younger adults: trends, possible causes, and the case for earlier screening [12:15]; Colonoscopy preparation: why bowel prep matters and how newer options improve the experience [16:45]; Colonoscopy quality, polyp miss rates, and personalized screening intervals [20:00]; Colonoscopy risks versus colorectal cancer risk: understanding the true risk-benefit tradeoff [29:30]; Non-invasive screening options for CRC: benefits, limitations, and their role alongside colonoscopy [37:00]; Colorectal cancer prevention principles: why screening matters and the role of colonoscopy [39:30]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

Join Dr. Jill Valerius and host Lee Henrikson as they continue a multi-part series discussing colon cancer screenings.

Drs. Wierda and O'Brien discuss how fixed-duration venetoclax-based therapy can match continuous BTK inhibitor treatment in CLL while offering deep remissions and time off therapy. They also explore promising real-world CAR T-cell (liso-cel) results and stress the growing importance of vaccination and cancer screening as CLL patients live longer.

The guidelines around cancer screening are changing to prioritize earlier evaluation and a more personalized approach to prevention. In this episode of the miniVHAN podcast, Ben Park, MD, director of the Vanderbilt-Ingram Cancer Center, discusses early detection and the lowering of recommended ages for certain screenings due to rising cancer rates in younger adults. He also encourages precision screening that accounts for an individual's genetics and family history, and advocates for shared decision-making to ensure patients feel respected and informed in their care journey.  

Advocates for people with prostate cancer want men to speak up about the need for a national screening programme. Prostate Cancer Foundation president Danny Bedingfield spoke to Ingrid Hipkiss.

In this episode, I'm joined by Dr. Dawn Mussallem, DO, an integrative oncologist, lifestyle medicine specialist, cancer survivor, heart transplant recipient, and the newly appointed Chief Medical Officer of Fountain Life.We talk about why cancer rates are rising, what we actually know about prevention, and why early detection matters so much when it comes to long-term outcomes. We also discuss the role of exercise, sleep, fiber, metabolic health, toxins, alcohol, gut health, screening tools, mammograms, full-body MRI, liquid biopsies, and why the basics still matter more than most people want to admit.Dr. Dawn also shares her extraordinary personal story: She is a stage 4 cancer survivor who went through chemotherapy and a bone marrow transplant at 26, developed cardiac toxicity from treatment 18 years later, received a heart transplant, and became the first person in the world to run a marathon within a year of receiving a new heart. Join the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women's health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you'll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.https://kayla-barnes-lentz.circle.so/checkout/become-a-memberIf you're already paying attention to protein, blood sugar, and longevity nutrition, fiber is one of the biggest gaps to fix. Zen Basil makes it simple to add more fiber, minerals, and prebiotic support into your routine with certified edible basil seeds that are tested for glyphosate and over 400 pesticides.Use the code KAYLA20 for 20% off.https://zenbasil.com/shopzenbasil/zenbasilseedbagIn this episode:- Why cancer is rising in younger people- The lifestyle factors linked to cancer prevention- Why exercise matters during and after cancer treatment- The role of sleep, insulin, and metabolic health- Fiber, gut health, and the microbiome- Mammograms, breast MRI, full-body MRI, and liquid biopsies- Soy, breast cancer myths, and plant protei- Hormone therapy, breast cancer risk, and screening- Why connection and purpose matter for longevityConnect with Kayla:Instagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter:https://x.com/femalelongevityWebsite:https://www.kaylabarnes.com/Spotify: https://open.spotify.com/show/4OLWWn22RGB0argbRPvAaQ?si=8e91b3c9e0ce4054Apple: https://podcasts.apple.com/us/podcast/longevity-optimization-with-kayla-barnes-lentz/id1591130227Follow Her Female Protocol: https://www.protocol.kaylabarnes.comLearn more about Dr. Dawn Mussallem:Instagram: https://www.instagram.com/drdawnmussallem/LinkedIn: https://www.linkedin.com/in/dawn-mussallem-do-dipablm-2b360b57/Website: https://www.fountainlife.com/#cancerprevention #breastcancer #femalelongevity #womenshealth #longevity #integrativeoncology #cancersurvivorship #earlydetection #breastcancerawareness #hormonehealth #metabolichealth #exerciseandcancer #soyandcancer #perimenopause #menopause #cancerresearch #preventivemedicine #healthoptimization #womenslongevity #fountainlife

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study shows the health benefits and health risks of an afternoon nap, rectal cancer rates rising for people in their 30’s and 40’s, and why he wouldn’t solely rely on a blood test to check […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study shows the health benefits and health risks of an afternoon nap, rectal cancer rates rising for people in their 30’s and 40’s, and why he wouldn’t solely rely on a blood test to check […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study shows the health benefits and health risks of an afternoon nap, rectal cancer rates rising for people in their 30’s and 40’s, and why he wouldn’t solely rely on a blood test to check […]

Interview with Yifan Zheng, MD

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken begin with drug companies and their pricing for medications, with most companies being headquartered hear in the US, yet Americans are charged far more for the same drugs as other countries. Next up, the FDA's approval for the first at-home cervical cancer screening, a bar code scanner helps consumers know what's really in their food and cosmetics, and how cinnamon might help our bodies absorb medication. When it comes to hearing aids, there is a problem with people getting older and experiencing loneliness, occurring mostly because they can't hear well enough to maintain essential, social connections. It appears to be a real problem with hearing aids countering an epidemic of loneliness among senior citizens. So, why do so many people, who are hard of hearing, refuse the help of modern hearing aids?In unfortunate medical news, there is a rise in adult patients becoming addicted to opioids with a new study confirming the drug use. The number of Americans using illicit opioids is 20x higher than previously estimated, with 11% of American adults report illicit opioid use within the last 12 months. Doug and Dr. Ken continue on with addressing listener questions, including supplements like Vitamin D and B12, addressing why the focus on these two supplements over any others. Vitamin D and B12 are essential for energy metabolism, immune system strengthening, and neurological health. They work together to improve gut health, with B12 supporting stomach acid production and D3 balancing the microbiome. Key benefits include improved cognitive function, bone health, nerve protection, and reduced fatigue, with combined supplementation often improving balance. Website: GoodDayHealthShow.com Social Media: @GoodDayNetworks

(From our Instagram Video Post): A very quick recap of the brand new ACOG Cervcial Caner Screening Update from April 24, 2026.

In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally the lost opportunity costs. You need to know these numbers to talk to your patients about the value or lack thereof of doing this test. […]

Bowel cancer is the biggest cause of cancer deaths in Kiwis under 50, but plenty of experts have raised concerns over the current screening process. New Zealand's national screening programme doesn't kick in until 58, and advocates are calling for more to be done to screen younger Kiwis. GP Dr Clive Price recently moved from the UK, and he's set up a screening company called Truescreen to fill the gaps. "It's about just filling that gap in the market, really, and offering a service to Kiwis." LISTEN ABOVESee omnystudio.com/listener for privacy information.

In this episode, Alyssa Aberle shares her powerful personal journey through a patient diagnosis, surgery, and tongue reconstruction, offering a perspective that deeply resonates with dental professionals. The conversation emphasizes the critical role hygienists play in early detection of oral cancer and why cutting corners is never an option when it comes to patient care.   Alyssa, along with David and Jessica, dives into practical strategies for oral cancer screenings, including how to communicate findings with confidence and compassion. They also discuss when and how to refer patients to specialists, ensuring the best possible outcomes. A key highlight is the discussion around effective screening scripts and the importance of the 10–14 day rule in monitoring suspicious lesions.   What We Talked About:   Alyssa's personal experience with her patients diagnosis, surgery, and tongue reconstruction   The responsibility of dental professionals to thoroughly screen for oral cancer   Why you should never cut corners during exams   How to confidently refer patients and choose the right specialist   Verbiage and scripts that build trust during oral cancer screenings   Understanding and applying the 10–14 day rule   Call to Action: This episode is designed to empower dental hygienists to take ownership of their role in patient care. By listening, you'll gain the confidence, language, and clinical mindset needed to perform thorough screenings and advocate for your patients' health.   Resources and Links: Connect with Alyssa: linktr.ee/alyssardh alyssa.aberle@gmail.com  

In this episode, Alyssa Aberle shares her powerful personal journey through a patient diagnosis, surgery, and tongue reconstruction, offering a perspective that deeply resonates with dental professionals. The conversation emphasizes the critical role hygienists play in early detection of oral cancer and why cutting corners is never an option when it comes to patient care.   Alyssa, along with David and Jessica, dives into practical strategies for oral cancer screenings, including how to communicate findings with confidence and compassion. They also discuss when and how to refer patients to specialists, ensuring the best possible outcomes. A key highlight is the discussion around effective screening scripts and the importance of the 10–14 day rule in monitoring suspicious lesions.   What We Talked About:   Alyssa's personal experience with her patients diagnosis, surgery, and tongue reconstruction   The responsibility of dental professionals to thoroughly screen for oral cancer   Why you should never cut corners during exams   How to confidently refer patients and choose the right specialist   Verbiage and scripts that build trust during oral cancer screenings   Understanding and applying the 10–14 day rule   Call to Action: This episode is designed to empower dental hygienists to take ownership of their role in patient care. By listening, you'll gain the confidence, language, and clinical mindset needed to perform thorough screenings and advocate for your patients' health.   Resources and Links: Connect with Alyssa: linktr.ee/alyssardh alyssa.aberle@gmail.com  

What if the moment women stop seeing their gynecologist is exactly when their cervical cancer risk matters most? Nenrot S. Gopep, a physician and public health researcher, joins the show to discuss her KevinMD article, "Menopause and the drop in cervical cancer screening." Her research found that postmenopausal women are 24 percent less likely to receive a Pap smear compared to premenopausal women, even after controlling for insurance, age, and socioeconomic status. You will hear why the persistent myth that cervical cancer is only a concern for sexually active women is keeping older patients from getting screened, and why HPV can lie dormant for years before developing into cancer. Gopep explains how the shift away from gynecologists after menopause places greater responsibility on primary care physicians to continue screening through age 65. She also discusses the expanded availability of the HPV vaccine, what Australia's elimination of cervical cancer teaches us about what is possible, and the specific questions patients should be asking their doctors about screening and vaccination. If you or someone you care about has put off cervical cancer screening after menopause, this episode could change that decision. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Discover how a first-year medical student revolutionized healthcare by inventing a non-invasive, RNA-based screening test for colorectal cancer. Join us as Dr. Erica Barnell shares the incredible journey of building Geneoscopy, raising over $112 million, and navigating the complex path to FDA approval.   In this episode of Born in Silicon Valley, Erica dives into the challenges and triumphs of being a first-time founder in the highly regulated medical device space. She reveals how her early research led to the creation of ColoSense, a groundbreaking at-home diagnostic tool designed to detect early-stage cancer and significantly improve patient compliance compared to traditional methods.   Erica also discusses the unique dynamics of building a biotech startup alongside her brother, highlighting how their complementary skill sets helped them navigate the volatile entrepreneurial landscape. From managing resources effectively to maintaining a positive company culture in a historically rigid industry, her insights are invaluable for anyone looking to scale a life sciences company.   Furthermore, we explore how Geneoscopy successfully executed a decentralized clinical trial during the height of the global pandemic. By leveraging social media for patient enrollment and drop-shipping collection kits directly to homes, they managed to complete their massive 10,000-patient study on time and significantly under budget.   00:00 - Welcome to the Show 00:58 - Dr. Barnell's Background and Origin Story 02:56 - The Benefits of Being a First-Time Founder 04:36 - Pros and Cons of a Sibling Co-Founder 06:15 - The Inspiration Behind ColoSense 08:10 - Market Competition and RNA vs. DNA Accuracy 10:19 - Colorectal Cancer Statistics and Prevention 11:40 - Target Market Size and Screening Compliance 13:38 - Crucial Lessons Learned as an Entrepreneur 14:59 - The Defining Moment and Awaiting FDA Approval 16:51 - Healthcare Marketing Strategies 18:46 - Pivoting During COVID and Decentralized Trials 21:15 - Hiring Secrets and Leveraging Consultants 22:43 - Building a Positive Company Culture 24:27 - Overcoming Market Challenges and Conserving Capital 26:08 - The Future Roadmap and Inflammatory Bowel Disease 27:26 - Where to Find Genoscopy and Conclusion   Host: Jake Aaron Villarreal leads the top AI recruitment firm in Silicon Valley, www.matchrelevant.com, uncovering stories of funded startups and going behind the scenes to tell their founders' journeys. If you are growing an AI startup or have a great story to tell, email us at: jake.villarreal@matchrelevant.com

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter takes a deep dive into prostate cancer screening, explaining why advanced and metastatic diagnoses continue to rise despite the availability of screening tools, and what can be done to reverse this trend. He breaks down what PSA actually measures and why it is far more informative when tracked over time rather than interpreted as a single value, and he explores how tools like MRI, PSA density, PSA velocity, and improved biopsy techniques can both reduce unnecessary procedures and improve the detection of aggressive cancers. Peter also discusses the role of active surveillance in avoiding overtreatment for low-risk cases, examines the flawed evidence that has historically been used to argue against PSA screening, and highlights how medications like finasteride can suppress PSA levels and potentially mask warning signs if not properly accounted for. Ultimately, he makes a compelling case for the importance of regular PSA testing as a key strategy in the effort to eliminate prostate cancer mortality. We discuss: The failure of current prostate cancer screening guidelines, and the rise in advanced disease despite available tools [2:30]; PSA screening fundamentals: benefits, harms, and the guideline shift driven by overdiagnosis concerns [5:30]; The impact of reduced PSA screening: rising rates of late-stage prostate cancer and worsening population-level outcomes [12:00]; How modern screening practices use PSA trends, MRI, and new imaging advances to improve accuracy and reduce unnecessary procedures [15:00]; Advances in prostate biopsy: transperineal approach improves safety and cancer detection [23:00]; Reducing overtreatment: Gleason scoring and active surveillance in modern prostate cancer care [25:30]; Reevaluating PSA screening guidelines: how flaws in the PLCO trial undermine the evidence used to argue against PSA screening [29:45]; Prostate cancer screening today: improved tools, flawed guidelines, and preventable mortality [33:45]; How finasteride and similar drugs suppress PSA levels and can lead to missed or delayed prostate cancer diagnoses if not properly accounted for [38:00]; The optimistic future of prostate cancer: modern screening advances and the potential to reduce mortality [43:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

In this episode of A Tale of Two Hygienists, co-hosts David Torres and Jessica Atkinson welcome renowned speaker and dental educator Jo-Anne Jones for an impactful conversation titled "Oral Cancer Screening: Stepping Fully Into Your Role."   Jo-Anne shares deeply personal and professional insights that challenge clinicians to recognize the true life-saving potential of routine dental visits. Through powerful storytelling and clinical expertise, she highlights the urgency of early detection—especially in the face of rising HPV-related cancers—and encourages hygienists to fully embrace their role in comprehensive screenings.   From explaining the intraoral "triangle of death" to demonstrating proper neck palpation techniques, Jo-Anne provides practical, actionable strategies clinicians can implement immediately. She also reflects on how a personal crisis shaped her mission in dentistry and reinforces why every screening appointment should be treated as an opportunity to save a life.   This episode is both inspiring and educational, equipping dental professionals with the knowledge and confidence to elevate their oral cancer screening protocols and patient care.   "What We Talked About (From Jo-Anne's Perspective)" Why Jo-Anne is passionate about saving lives—HPV, rising cancers, and one family's loss How Jo-Anne approaches the intraoral "triangle of death" exam How a personal crisis launched Jo-Anne's mission in dentistry Why Jo-Anne believes this is a life-saving appointment How Jo-Anne performs proper neck palpation Simple screening steps Jo-Anne recommends hygienists start today Why Jo-Anne uses screening tools in clinical practice Call to Action   If you found this episode valuable, be sure to subscribe to A Tale of Two Hygienists, leave a review, and share it with colleagues who are committed to improving patient care and early detection.   Resources:   HPV Talking Points Resource: www.rdhu.ca/hpvtalkingpointsresource   Instagram: https://www.instagram.com/jjlifeandtimes/   LinkedIn: https://www.linkedin.com/in/jo-anne-jones-88a2266/   Facebook: https://www.facebook.com/jo.anne.jones.626106/

Better health outcomes often come from slowing down and asking a harder question: is this test actually serving me, or is it serving the system?In this episode, Dr. Stephen Petteruti talks through the reality behind prostate cancer screening—what's driving it, who's funding it, and where the standard approach falls short. He explains how free PSA screenings are often backed by pharmaceutical companies, why the commonly used PSA cutoff of 4 is an arbitrary number that creates unnecessary fear, and how the medical system can capitalize on men's anxiety around a cancer diagnosis. He walks through what a normal PSA trajectory looks like decade by decade, why the prostate rectal exam has been clinically invalidated, and how to interpret MRI results and PI-RADS scores without getting swept into reactive decision-making.Dr. Stephen offers a grounded way to think about it: understand your numbers in context, question every recommendation, and recognize that prostate cancer—for the vast majority of men—is something you live with, not something that kills you. The goal is to slow down, protect yourself from iatrogenic harm, and make decisions based on information rather than fear.The bigger message is simple and practical. Long-term prostate health is built through informed decision-making, not reactive testing. Screening still has a role, but it should be understood in context—not accepted on autopilot.If you're a man over 40 or you care about someone who is, spend a few minutes with this episode. Tune in now: Your Free Prostate Cancer Screening Is a Trap — Here Is the Truth.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Learn more: https://www.drstephenpetteruti.com/Learn more: https://www.intellectualmedicine.com/Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠Subscribe to Intellectual Medicine on:Apple Podcast: https://tinyurl.com/DrPetterutiApplePodcastSpotify: https://tinyurl.com/DrPetterutiSpotifyPodcastDisclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com

April 13, 2026- Just a few years after expanding health insurance coverage for Medicaid patients with cancer to include biomarker screenings, Gov. Kathy Hochul is looking to limit access to the diagnostic tool. We talk about the coverage fight in the state budget negotiations with Michael Davoli, senior director of government relations in New York for the American Cancer Society Cancer Action Network.

Early-onset cancers are rising—and they're forcing people to rethink cancer, screenings and care models.What if cancer care strategy needs to start earlier—and last longer? This Pharmacy Friends conversation breaks down the rise in early-onset cancers and the practical implications for prevention, benefit design, and affordability.00:00 Intro02:30 Basics of cancer in younger people07:52 Early onset cancer impact on health plans11:14 Patient challenges and decision making15:23 Impact on affordability22:00 Importance of medical and pharmacy benefit integration 27:38 New ways of offering cancer care30:41 Role that AI can play in patient care33:26 Should health care adapt for best clinical outcomes34:50 Being an advocate for the patient38:49 ClosingContent in this podcast is for informational or educational purposes only. The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

Lung cancer is one of the most common—and most misunderstood—conditions out there. The symptoms can be subtle, easy to ignore, or mistaken for something as simple as a cold.In this episode of Baptist HealthTalk, thoracic surgeon Dr. Ian Bostock breaks down what lung cancer really is, the early warning signs to watch for, and when it's time to talk to your doctor about screening.You'll learn: The difference between types of lung cancer  Why symptoms often don't appear early  Key warning signs you shouldn't ignore  Who should consider lung cancer screening  The truth about smoking, vaping, and risk  How early detection can save lives If you've ever wondered whether your symptoms are “just a cold” or something more serious, this is a must-listen.

Breast cancer screening is associated with false positives, where women are referred for further assessments and procedures that may be unnecessary. Does it help to stratify women based on risk factors like genetics before they have screening? Johns Hopkins Kimmel … Should breast cancer screening be targeted to those at greatest risk? Elizabeth Tracey reports Read More »

Colonoscopy is one of the most effective tools for preventing colorectal cancer—but it's not the only screening option. So how do you know when to get screened, which test to choose, and what to do next if results come back abnormal? Colorectal cancer is one of the most preventable cancers, yet many people delay screening due to confusion or uncertainty. In this Gastro Girl Podcast episode, developed in collaboration with the American College of Gastroenterology (ACG) Patient Care Committee, we're joined by leading gastroenterologist Dr. Aasma Shaukat (NYU Langone Health) and member of the U.S. Multi-Society Task Force on Colorectal Cancer. Dr. Shaukat breaks down colorectal cancer screening in a clear, practical way so you can make informed decisions and take the right next steps with confidence.   What you'll learn: When to start colorectal cancer screening—and who should start earlier Why colorectal cancer is rising in younger adults How family history affects your screening plan Colonoscopy vs stool-based tests—what's the difference What abnormal or incomplete results actually mean Why follow-up testing is critical to prevention How to advocate for the care you nee Why this matters: Early detection saves lives. Completing colorectal cancer screening—including follow-up after abnormal results—can prevent cancer before it starts. This episode is for educational purposes only and is not a substitute for medical advice. Always consult your healthcare provider about your individual care. Explore more trusted digestive health resources: Visit GastroGirl.com or download the Ask Gastro Girl app for evidence-based digestive health guidance you can trust.  

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/GEE865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 11, 2027.Real-World Strategies and Workflows for Lung Cancer Screening Success in Diverse Populations: Enhancing Vigilance to Increase Early Detection on the Front Lines of Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Program notes:0:35 New cholesterol lowering guidelines1:35 Risk scores new2:35 Mainstay is behavioral change3:35 For those with a longer view4:00 AI based glaucoma screening in primary care settings5:00 Either AI or pressure6:00 Fundus photograph and intraocular pressure7:00 Sensitivity and specificity7:50 Diet and brain structure8:50 Brain imaging over ten or fifteen years9:50 Diet that's been advocated for a long time10:55 Surveying wastewater for colorectal cancer markers11:55 CDH1 marker measurement12:55 Shows promise for intervention13:57 End

Program notes:0:44 Adolescents and sleep duration1:44 Very short sleep duration2:44 Increased among all subgroups3:45 Structural factors more important4:45 Moving school start later5:02 GLP1 agonists and various patient characteristics6:02 Greater weight loss in women7:06 A blood test to predict onset of symptomatic Alzheimer's8:06 Median error of 3-4 years9:06 Window of 11.4 years for an 80 year old10:05 Screening for colorectal cancer 11:05 Colonoscopy and FIT diagnosed early12:33 End

Joshua Jackson joins Dylan, Craig, and Al to discuss an important and personal message – the importance of screening for cancer. Also, a sneak peek of Craig's brand-new podcast “Glass Half Full”. Plus, father-daughter duo Phil and Lily Rosenthal on their new children's book “Just Try It! Someplace New!”. And, TODAY food stylist Krissy Downey demonstrates how to make a steakhouse-quality marinated skirt steak, baked potato, and lemony Ceasar salad with frico croutons.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Headlines:  – Welcome To Mo News (02:00) – NASA Eyes March Artemis II Launch After Hydrogen Leaks Delay Moon Mission (02:15) – US Fighter Jet Downs Iranian Drone Near Aircraft Carrier, Gunboats Approach US-Flagged Tank (06:20) – Iran Demands Changes In Venue And Scope Of Talks With US (09:20) – Trump Wants To ‘Nationalize The Voting,' Seeking To Grab States' Power (11:00) – Police Say They're Aware Of ‘Possible Ransom' Note for Savannah Guthrie's Mom (19:30) – Trump Calls Epstein Files “Waste Of Time” And Urges DOJ To Move On (23:00) – AI Use In Breast Cancer Screening Cuts Rate Of Later Diagnosis By 12%, Study Finds (30:00) – PepsiCo Cutting Price of Doritos, Cheetos And Other Snack By Up To 15% (32:00) – Lindsey Vonn Plans To Compete In The Winter Olympics Despite A Ruptured ACL (33:50) – On This Day In History (37:00) Thanks To Our Sponsors:  –⁠ Industrious⁠ - Coworking office. 50% off day pass | Code: MONEWS50 – Incogni - 60% off an annual plan| Code: MONEWS – Monarch - 50% off your first year | Code: MONEWS – Factor - 50% off your first box | Code: monews50off – ShipStation - Try for free for 60 days | Code: MONEWS